Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis.
Rabitsch W, Bojic M, Wohlfarth P, Leiner M, Schörgenhofer C, Kalhs P, Schulenburg A, Sillaber C, Mitterbauer M, Sperr WR, Jäger U, Skrabs K, Greinix H, Hermann A, Lamm W. Rabitsch W, et al. Among authors: mitterbauer m. J Cancer Res Clin Oncol. 2016 Jun;142(6):1307-14. doi: 10.1007/s00432-016-2134-3. Epub 2016 Feb 26. J Cancer Res Clin Oncol. 2016. PMID: 26920356 Free PMC article.
Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia.
Gaiger A, Schmid D, Heinze G, Linnerth B, Greinix H, Kalhs P, Tisljar K, Priglinger S, Laczika K, Mitterbauer M, Novak M, Mitterbauer G, Mannhalter C, Haas OA, Lechner K, Jäger U. Gaiger A, et al. Among authors: mitterbauer m, mitterbauer g. Leukemia. 1998 Dec;12(12):1886-94. doi: 10.1038/sj.leu.2401213. Leukemia. 1998. PMID: 9844919
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Greinix HT, Loidolt H, Rabitsch W, Schulenburg A, Keil F, Mitterbauer M, Laczika K, Lechner K, Dieckmann K, Fischer G, Jäger U, Rosenmayr A, Knöbl P, Schwarzinger I, Höcker P, Mannhalter C, Hinterberger W, Haas OA, Fonatsch C, Kalhs P. Greinix HT, et al. Among authors: mitterbauer m. Ann Hematol. 2000 Apr;79(4):206-13. doi: 10.1007/s002770050580. Ann Hematol. 2000. PMID: 10834508 Clinical Trial.
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Keil F, Prinz E, Kalhs P, Lechner K, Moser K, Schwarzinger I, Jäger U, Fonatsch C, Worel N, Mannhalter C, Rabitsch W, Loidolt H, Schulenburg A, Mitterbauer M, Höcker P, Greinix HT. Keil F, et al. Among authors: mitterbauer m. Leukemia. 2001 Mar;15(3):355-61. doi: 10.1038/sj.leu.2402048. Leukemia. 2001. PMID: 11237057
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.
Mitterbauer M, Neumeister P, Kalhs P, Brugger S, Fischer G, Dieckmann K, Hoecker P, Hinterberger W, Linkesch W, Simonitsch I, Jaeger U, Lechner K, Mannhalter C, Mitterbauer G, Greinix HT. Mitterbauer M, et al. Among authors: mitterbauer g. Leukemia. 2001 Apr;15(4):635-41. doi: 10.1038/sj.leu.2402053. Leukemia. 2001. PMID: 11368367
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K, Mitterbauer G, Mitterbauer M, Knöbl P, Schwarzinger I, Greinix HT, Rabitsch W, Fonatsch C, Mannhalter C, Lechner K, Jaeger U. Laczika K, et al. Among authors: mitterbauer m, mitterbauer g. Leuk Lymphoma. 2001 Sep-Oct;42(5):923-31. doi: 10.3109/10428190109097711. Leuk Lymphoma. 2001. PMID: 11697647 Clinical Trial.
62 results